Scilex Holding Company (SCLXW)

USD 0.21

(-23.88%)

Total Assets Summary of Scilex Holding Company

Scilex Holding Company's latest annual total assets in 2023 was 101.3 Million USD , up 17.08% from previous year.
Scilex Holding Company's latest quarterly total assets in 2024 Q1 was 91.24 Million USD , down -9.94% from previous quarter.
Scilex Holding Company reported annual total assets of 86.52 Million USD in 2022, up 11.03% from previous year.
Scilex Holding Company reported annual total assets of 77.93 Million USD in 2021, down -4.38% from previous year.
Scilex Holding Company reported quarterly total assets of 104.54 Million USD for 2024 Q2, up 14.58% from previous quarter.
Scilex Holding Company reported quarterly total assets of 86.05 Million USD for 2023 Q1, down -0.55% from previous quarter.

Annual Total Assets Chart of Scilex Holding Company (2023 - 2020)

Historical Annual Total Assets of Scilex Holding Company (2023 - 2020)

Year	Total Assets	Total Assets Growth
2023	101.3 Million USD	17.08%
2022	86.52 Million USD	11.03%
2021	77.93 Million USD	-4.38%
2020	81.5 Million USD	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	91.24 Million USD	-9.94%
2024 Q2	104.54 Million USD	14.58%
2023 Q1	86.05 Million USD	-0.55%
2023 Q3	80.52 Million USD	-36.32%
2023 FY	101.3 Million USD	17.08%
2023 Q4	101.3 Million USD	25.81%
2023 Q2	126.46 Million USD	46.96%
2022 FY	86.52 Million USD	11.03%
2022 Q2	142.29 Million USD	0.94%
2022 Q3	88.77 Million USD	-37.61%
2022 Q4	86.52 Million USD	-2.53%
2022 Q1	140.97 Million USD	0.75%
2021 Q2	139.89 Million USD	-0.12%
2021 Q1	140.06 Million USD	587.38%
2021 Q3	139.64 Million USD	-0.18%
2021 FY	77.93 Million USD	-4.38%
2021 Q4	139.92 Million USD	0.2%
2020 Q3	20.37 Million USD	0.0%
2020 Q4	20.37 Million USD	0.0%
2020 FY	81.5 Million USD	0.0%
2020 Q2	20.37 Million USD	0.0%
2020 Q1	20.37 Million USD	0.0%

Peer Total Assets Comparison of Scilex Holding Company

Name	Total Assets	Total Assets Difference
Amgen Inc.	97.15 Billion USD	99.896%
AstraZeneca PLC	101.11 Billion USD	99.9%
Biogen Inc.	26.84 Billion USD	99.623%
Gilead Sciences, Inc.	62.12 Billion USD	99.837%
MIRA Pharmaceuticals, Inc.	4.93 Million USD	-1953.931%
Scilex Holding Company	101.3 Million USD	0.0%